Prostate-specific antigen is a predictor of the efficacy of salvage radiation therapy in patients with recurrent prostate cancer after radical prostatectomy

by Р. V. Bulychkin, S. I. Tkachev, V. B. Matveev, A. V. Nazarenko
Published 2019-07-01